Verdye™ Indocyanine Green (ICG)

Verdye ICG is the leading fluorescence product trusted by physicians worldwide, to guide their treatment procedures, based on fluorescence

THIS INFORMATION IS INTENDED FOR UK HEALTHCARE PROFESSIONALS ONLY.

Type: Prescription Only Medicine (POM)
Product: Verdye 5 mg/ml powder for solution for injection

Verdye™ Indocyanine Green (ICG) - Image 2

Verdye™ Indocyanine Green (ICG) - Image 3

Verdye™ Indocyanine Green (ICG) - Image 4

Verdye™ Indocyanine Green (ICG) - Image 5

Verdye™ Indocyanine Green (ICG) - Image 6

Key Features & Clinical Benefits

Designed in collaboration with cardiologists to solve the most common challenges in radial hemostasis.

Flexible Dosing

Verdye ICG enables indication-specific dosing, based where applicable on patient body weight. The vial presentation supports straightforward reconstitution and accurate withdrawal of the required dose.

Administration

Verdye ICG can be administered intradermally, subcutaneously, peritumorally or intravenously, according to the clinical indication and in accordance with the SmPC.

Supply Reliability

The five-year shelf life helps reduce the risk of stock expiry, simplifies inventory management and supports more efficient procurement and stock planning.

Product Overview

This medicinal product is for diagnostic use only. Compatible near-infrared imaging systems detect and display ICG fluorescence, providing visual information to support diagnostic assessment and procedural guidance. Verdye ICG is being used by surgeons worldwide across a range of procedures, with more than 11,000 published articles covering its use and applications.* Over 20 years of pharmacovigilance data** and clinical experience are complemented by Kimal’s dedicated field-based Clinical Specialists, providing support for theatre sessions, teaching and training.

Approved diagnostic indication for Verdye ICG in the UK

Cardiac, circulatory and micro-circulatory diagnostics:

measurement of cardiac output and stroke volume
measurement of circulating blood volumes
measurement of cerebral perfusion

Liver function diagnostics:

measurement of liver blood flow
measurement of excretory function of the liver

Ophthalmic angiography diagnostics:

measurement of perfusion of the choroid

Breast cancer:

Intraoperative identification of sentinel lymph nodes and visualization of lymphatic pathways.

Safety Profile:

Nausea – Very rare (˂1/10,000)
Urticaria – Very Rare (˂1/10,000)
Anaphylactoid or anaphylactic reactions – Very Rare (˂1/10,000)

REGULATORY INFO Adverse reactions should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse reactions should also be reported to info@diagnosticgreen.com This website contains promotional material for Verdye™, a prescription-only medicine. Always read the label and the Prescribing information carefully before use. Information about this product, including adverse reactions, precautions, contra-indications, and method of use can be found at https://diagnosticgreen.com/row/icgpharmaceutical- product/. Please consult the Summary of Product Characteristics and patient information leaflet for full prescribing information. Marketing authorisation holder Diagnostic Green Limited, Athlone Business and Technology Park, Garrycastle, Athlone, N37 F786, Ireland PL 56699/0001 Verdye^™ is a trademark of Diagnostic Green and is distributed by Kimal PLC only in the UK. NHS pricing: £152.98 NHS list price REFERENCES & SOURSES: * Source: PubMed ** Diagnostic Green pharmacovigilance data

Clinical Applications

Ophthalmic Angiography Diagnostics

Liver Function Diagnostics

Cardiac, Circulatory and Micro-Circulatory Diagnostics

Breast cancer

Intraoperative Identification of Sentinel Lymph Nodes and Visualization of Lymphatic Pathways in Breast Cancer.

Product Highlight

Discover the latest clinical evidence supporting Verdye ICG as a standalone tracer for sentinel lymph node biopsy in breast cancer. New UK Study Supports ICG-Only Sentinel Lymph Node Biopsy in Breast Cancer. A prospective UK cohort study, published in the Annals of Surgical Oncology as a follow-on to the INFLUENCE trial, evaluated Verdye as the sole tracer across 300 consecutive sentinel lymph node biopsy procedures in breast cancer patients. The study reported a 99.7% nodal procedural detection rate and 97.7% ICG fluorescent nodal detection, with performance remaining consistent regardless of patient age, BMI, or tumour size, and no ICG-related adverse events recorded. These findings, from one of the largest prospective UK evaluations of ICG as a standalone tracer, support its use as a practical, reliable alternative to traditional dual-tracer techniques in routine clinical practice.

Technical Assets

Brochure

PDF

Questions about this product?

Speak to our team for more information, product details or support with your enquiry.

Technical Specifications

Active substance:	Indocyanine Green (lyophilised powder)
Purpose of use:	Diagnostic procedures using fluorescence imaging
Pharmaceutical form:	Powder for solution for injection: Dark-green power
Number of units per pack:	5 x 25 mg vials
Concentration:	5 mg/ml
List of excipients:	Non

Ordering Information

Product Code (Sterile)	Product Description
PICG0025UK	Verdye (Indocyanine Green) 5mg/ml Injection

Related Products

Cataract Procedure Pack

Procedure packs bring together sterile, single use and disposable surgical items required for a procedure; delivering improvements in efficiency, traceability, cost savings and reducing the risk of infection. Procedure packs can be tailored to meet your exact needs and the components and packs listed represent universal options.